Colonial Trust’s Astera Labs ALAB Stock Holding History

Colonial Trust’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-36	Closed	-$3.25K	–	1132
2025 Q2	$3.25K	Buy	+36	New	+$2.84K	﹤0.01%	908

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Colonial Trust's ALAB Position: Q3 2025 in Review

Colonial Trust sold out of Astera Labs (ALAB) in Q3 2025, closing a stake of 36 shares — an estimated $3.25K sold.

Colonial Trust first reported a position in ALAB in Q2 2025 and held it in 1 quarter. The position peaked at $3.25K in Q2 2025. 657 funds tracked by Wall St. Rank hold ALAB as of Q3 2025.

Colonial Trust reported no remaining Astera Labs position as of Q3 2025 after selling out during the quarter.
Colonial Trust sold 36 Astera Labs shares in Q3 2025, an estimated $3.25K.
Colonial Trust first reported a position in Astera Labs in Q2 2025 and held it in 1 quarter.
Colonial Trust's Astera Labs position peaked at $3.25K in Q2 2025.
657 funds tracked by Wall St. Rank held Astera Labs as of Q3 2025.

Based on Colonial Trust's 13F filing for Q3 2025, filed 10 Nov 2025.